Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: PBRM1
Total 1 results
Lynkcell Europe
Available
An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)
Kidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Sponsors and Collaborators
Junta de Andalucía - Consejería de Salud y Familias, Spain
Mexican Emerging Infectious Diseases Clinical Research Network
Hospital Sirio-Libanes Ensino e Pesquina
Narhalsan primary care rehabilitation
GTEI
Castleton University
Belfast Arthroplasty Research Trust (BART)
José Castro
Biotics, Inc.
MB Clinical Research, LLC
Fabian Rohner
Department of Cardiology, Lausanne University Center Hospital, Lausanne, Switzerland
Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)
Don Cockcroft
Universität Tübingen
Bon Secours Pediatric Dental Associates
Damagen Genetic Diagnostic Center
Crowley Carter Foundation
Shanghai IxCell Biotechnology Co., LTD
University of Valladolid
View Full List
Medical Conditions
Milk Expression, Breast
Chronic Arthritis, Longer Than Six Weeks Duration
Stage V Wilms Tumor
Vascular Aging
Infarction, Myocardial
Cryptococcosis or Aspergillosis Infections
Lung Cancer Non Small Cell
Adolescent Oncology Patients
Vesicoureteral Reflux (VUR)
Gallbladder and Bile Duct Calculi
Refractory Childhood Epilepsy
Nasotracheal Intubation
Health Services, Geriatric
Syndrome Heart Disease
Cystic Fibrosis in Adults, Chronic Colonization With Pseudomonas Aeruginosa
Residual Curarization
Support Groups
Lenses
Congenital Nephrogenic Diabetes Insipidus
PSA Level Greater Than or Equal to 0.5
View Full List
Drug Interventions
Lidocaine, epinephrine (Local anesthetic)
Dapagliflozin
Etanercept
Cabozantinib
SNAC
Fluorescein + ALA
PF-05212384
PEP005 Gel
Granulocyte colony-stimulating factor (G-CSF)
Sulfasalazine
Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase
Trimetazidine 35 mg
ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
Axitinib plus toripalimab
Azacitidine
Metoprolol succinate sustained-release tablet
Gliadel Wafer
ABT-199
Fluorouracil
Quadratus Lumborum Block type 2
View Full List
CROs by country
Contract Research Organizations in Australia
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Belgium
Contract Research Organizations in El Salvador
Contract Research Organizations in Ethiopia
Contract Research Organizations in Ireland
Contract Research Organizations in New Zealand
Contract Research Organizations in Panama
Contract Research Organizations in Romania
Contract Research Organizations in Slovakia
Contract Research Organizations in Tunisia
Contract Research Organizations in Türkiye
Contract Research Organizations in Uruguay
CRO list by country
CROs in Serbia
Syneos Health
PPD
Dokumeds
IQVIA
SanaClis
ACROSS Global
Fidelis Research
PrimeVigilance
ICON
Parexel
All CROs in Serbia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe